Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 24 citing articles:

Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis
Zhenyu Zhu, Yuxiu Gu, Cuirong Zeng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 41
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
Raghunath Singh, Nicolette Stogios, Emily R. Smith, et al.
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 31
Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery
Srinivas Kamath, Andrea M. Stringer, Clive A. Prestidge, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 10, pp. 1315-1331
Closed Access | Times Cited: 21
Probiotic Mechanisms Affecting Glucose Homeostasis: A Scoping Review
Maša Primec, Tomaž Langerholc
Life (2022) Vol. 12, Iss. 8, pp. 1187-1187
Open Access | Times Cited: 23
Emerging epigenetic dynamics in gut-microglia brain axis: experimental and clinical implications for accelerated brain aging in schizophrenia
Benneth Ben‐Azu, Elisabetta C. del Re, Jared VanderZwaag, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 15
When the microbiome helps the brain‐current evidence
Jovana Drljača, Nаtаsа Мilоsеvic, Maja Milanović, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. S1, pp. 43-58
Open Access | Times Cited: 14
Altered gut microbiota and systemic immunity in Chinese patients with schizophrenia comorbid with metabolic syndrome
Zongxin Ling, Zhiyong Lan, Yiwen Cheng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Metabolomic Connections between Schizophrenia, Antipsychotic Drugs and Metabolic Syndrome: A Variety of Players
Juan D. Molina, Sonia Avila, Gabriel Rubio, et al.
Current Pharmaceutical Design (2021) Vol. 27, Iss. 39, pp. 4049-4061
Open Access | Times Cited: 28
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 21
Probiotic for Pancreatic β-Cell Function in Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
Maryana Savytska, Dmytro Kyriienko, Iuliia Komisarenko, et al.
Diabetes Therapy (2023) Vol. 14, Iss. 11, pp. 1915-1931
Open Access | Times Cited: 13
Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness
Nazarii Kobyliak, Maria Khomenko, Tetyana Falalyeyeva, et al.
Critical Reviews in Microbiology (2023) Vol. 50, Iss. 5, pp. 663-683
Closed Access | Times Cited: 11
Does the gut microbiome mediate antipsychotic-induced metabolic side effects in schizophrenia?
Svetlina Vasileva, J. Tucker, Dan Siskind, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 5, pp. 625-639
Closed Access | Times Cited: 17
The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications
Hui Chen, Ting Cao, Bikui Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain
豊田 隆謙, Xiaoyan He, Y. Liu, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 10
Probiotics Supplementation for Improving Glucolipid Parameters in Individuals with Prediabetes: A Systematic Review and Meta-Analysis of Randomized Trials
Karunia Valeriani Japar, Timotius Ivan Hariyanto, Damian Vidana Hamzah, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Akkermansia muciniphila ameliorates olanzapine-induced metabolic dysfunction-associated steatotic liver disease via PGRMC1/SIRT1/FOXO1 signaling pathway
Hui Chen, Ting Cao, Chenquan Lin, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Lack of genotoxicity and subchronic toxicity in safety assessment studies of Akkermansia muciniphila formulation
Esther S. Yu, John Eid, Andrew Cheng, et al.
Toxicology Reports (2024) Vol. 13, pp. 101790-101790
Open Access | Times Cited: 2
Microbiome First Approaches to Rescue Public Health and Reduce Human Suffering
Rodney R. Dietert
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1581-1581
Open Access | Times Cited: 11
B-GOS alleviates olanzapine-induced lipid disturbances in mice by enriching Akkermansia and upregulation of PGRMC1-Wnt signaling
Cuirong Zeng, Hui Chen, Ting Cao, et al.
Food and Chemical Toxicology (2024) Vol. 185, pp. 114490-114490
Closed Access | Times Cited: 1
A Possible Role of Akkermansia muciniphila in the Treatment of Olanzapine-Induced Weight Gain
F. Bertossi
Cureus (2024)
Open Access | Times Cited: 1
The Role of Probiotics in Managing Glucose Homeostasis in Adults with Prediabetes: A Systematic Review and Meta-Analysis
Chao Sun, Qingyin Liu, Xiaona Ye, et al.
Journal of Diabetes Research (2024) Vol. 2024, pp. 1-17
Open Access | Times Cited: 1
The efficacy of Lactobacillus and Bifidobacterium in patients with schizophrenia: a meta-analysis
Mi Yang, Xi Cui, Di Kong, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access | Times Cited: 1
Metformin acts on the gut-brain axis to ameliorate antipsychotic-induced metabolic dysfunction
Xiaorong Wang, Huimin Huang, Yiyi Zhu, et al.
BioScience Trends (2021) Vol. 15, Iss. 5, pp. 321-329
Open Access | Times Cited: 6
Il ruolo del microbiota nell'aumento ponderale associato alla terapia antipsicotica
F. Bertossi
PNEI REVIEW (2022), Iss. 2, pp. 108-122
Closed Access
Page 1

Scroll to top